文献
J-GLOBAL ID:201702237453282372
整理番号:17A1443366
2型糖尿病および慢性腎臓病患者におけるシタグリプチンの安全性:TECOSの結果【Powered by NICT】
Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS
著者 (13件):
Engel Samuel S.
(Merck & Co., Inc., Kenilworth, New Jersey)
,
Suryawanshi Shailaja
(Merck & Co., Inc., Kenilworth, New Jersey)
,
Stevens Susanna R.
(Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina)
,
Josse Robert G.
(St. Michael’s Hospital, University of Toronto, Toronto, Canada)
,
Cornel Jan H.
(Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands)
,
Cornel Jan H.
(Working group on Cardiovascular Research the Netherlands (WCN), Utrecht, the Netherlands)
,
Jakuboniene Neli
(Department of Endocrinology, Lithuanian University of Health Sciences, Kaunas, Lithuania)
,
Riefflin Axel
(GMP Husby, Husby, Germany)
,
Tankova Tsvetalina
(Clinical Center of Endocrinology, Medical University, Sofia, Bulgaria)
,
Wainstein Julio
(Wolfson Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel)
,
Peterson Eric D.
(Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina)
,
Holman Rury R.
(Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK)
,
on behalf of the TECOS Study Group
資料名:
Diabetes Obesity & Metabolism
(Diabetes Obesity & Metabolism)
巻:
19
号:
11
ページ:
1587-1593
発行年:
2017年
JST資料番号:
W2549A
ISSN:
1462-8902
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)